ARTICLE | Clinical News
Digibind digoxin immune fab regulatory update
December 3, 2012 8:00 AM UTC
FDA granted Fast Track designation for Glenveigh's digoxin immune fab to treat severe preeclampsia. The polyclonal antibody fragment that neutralizes digoxin is clinical testing to treat eclampsia and...